MAPT and Alzheimer disease: These inflammatory mediators play a crucial role in driving neuroinflammation and are associated with the hyperphosphorylation of Tau protein and Aβ pathologies, ultimately leading to the formation of amyloid plaques, NETs, and subsequent neuronal dysfunction observed during the aging process and in the cortex of AD patients [21,22,23,24].